FCF Margin % is calculated as Free Cash Flow divided by its Revenue. TELA Bio's Free Cash Flow for the
three
months ended in Sep. 2024 was $-9.11 Mil. TELA Bio's Revenue for the
three
months ended in Sep. 2024 was $18.96 Mil. Therefore, TELA Bio's FCF Margin % for the quarter that ended in Sep. 2024 was -48.03%.
The historical rank and industry rank for TELA Bio's FCF Margin % or its related term are showing as below:
TELA'
s FCF Margin % Range Over the Past 10 Years
Min: -388.27 Med: -135.19 Max: -67.07
Current: -67.07
During the past 7 years, the highest FCF Margin % of TELA Bio was -67.07%. The lowest was -388.27%. And the median was -135.19%.
TELA's FCF Margin % is ranked worse than 75.52% of 825
companies
in the Medical Devices & Instruments industry
Industry Median: -4.42
vs TELA: -67.07
TELA Bio FCF Margin % Historical Data
The historical data trend for TELA Bio's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, TELA Bio's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TELA Bio's FCF Margin % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, TELA Bio's FCF Margin % distribution charts can be found below:
* The bar in red indicates where TELA Bio's FCF Margin % falls into.
TELA Bio FCF Margin % Calculation
FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.
TELA Bio's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TELA Bio FCF Margin % Related Terms
Thank you for viewing the detailed overview of TELA Bio's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
TELA Bio Inc is a United States-based medical technology company. The company is involved in developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. Its reinforced tissue matrices called OviTex improve the clinical outcomes and reduce costs of care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery. The company's second portfolio of products, the OviTex PRS Reinforced Tissue Matrix, addresses unmet needs in plastic and reconstructive surgery.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TELA has been successfully added to your 